Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.21 - $0.39 $14,204 - $26,379
67,641 Added 325.26%
88,437 $19,000
Q1 2022

May 17, 2022

SELL
$0.34 - $0.5 $28,725 - $42,243
-84,486 Reduced 80.25%
20,796 $8,000
Q4 2021

Feb 17, 2022

BUY
$0.41 - $0.68 $29,588 - $49,072
72,166 Added 217.92%
105,282 $51,000
Q3 2021

Nov 12, 2021

SELL
$0.53 - $0.91 $13,555 - $23,275
-25,577 Reduced 43.58%
33,116 $18,000
Q2 2021

Sep 17, 2021

BUY
$0.57 - $0.99 $8,172 - $14,194
14,338 Added 32.33%
58,693 $42,000
Q1 2021

May 19, 2021

SELL
$0.49 - $1.28 $14,258 - $37,246
-29,099 Reduced 39.62%
44,355 $37,000
Q4 2020

Feb 24, 2021

BUY
$0.36 - $0.55 $26,443 - $40,399
73,454 New
73,454 $33,000
Q2 2020

Aug 07, 2020

SELL
$0.39 - $0.71 $13,916 - $25,334
-35,683 Closed
0 $0
Q4 2019

Feb 04, 2020

SELL
$0.22 - $0.27 $1,584 - $1,944
-7,200 Reduced 16.79%
35,683 $8,000
Q3 2019

Nov 20, 2019

BUY
$0.25 - $0.31 $3,507 - $4,349
14,030 Added 48.63%
42,883 $11,000
Q2 2019

Aug 13, 2019

BUY
$0.24 - $0.51 $6,924 - $14,715
28,853 New
28,853 $9,000
Q1 2019

Apr 12, 2019

SELL
$0.23 - $0.35 $22,503 - $34,244
-97,840 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$0.2 - $0.45 $19,568 - $44,028
97,840 New
97,840 $25,000
Q2 2018

Jul 30, 2018

SELL
$0.21 - $0.32 $3,072 - $4,682
-14,633 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$0.21 - $0.32 $111 - $169
-529 Reduced 3.49%
14,633 $3,000
Q1 2018

May 14, 2018

SELL
$0.17 - $0.58 $2,825 - $9,640
-16,622 Reduced 52.3%
15,162 $5,000
Q4 2017

Feb 09, 2018

SELL
$0.16 - $0.2 $7,153 - $8,941
-44,707 Reduced 58.45%
31,784 $6,000
Q3 2017

Nov 15, 2017

BUY
$0.17 - $0.2 $13,003 - $15,298
76,491
76,491 $0

Others Institutions Holding CPHI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About CHINA PHARMA HOLDINGS, INC.


  • Ticker CPHI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 50,449,700
  • Market Cap $8.58M
  • Description
  • China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. It...
More about CPHI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.